Recent Finacing
Recent Raise
AxioMx provides in vitro, high-throughput discovery and development of synthetic monoclonal antibody fragments—offering antigen design, affinity maturation, and custom reagents for research, diagnostics, and therapeutics.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors